Evidence map›Paper›PMID 42814786›Full record

ArticlePLoS genetics2026

The prevalence of protein misfolding as a mechanism for hereditary deafness.

Rose A Gogal, Genevieve M Cox, Diana L Kolbe, Amanda M Odell, Chloe E Ovel, Katherine I McCormick, Brian Hong, Hela Azaiez, Thomas L Casavant, Richard J H Smith and 2 more

Abstract read
In one paragraph

Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rose A GogalRoy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, United States of America.ORCID https://orcid.org/0000-0001-9550-6415
Genevieve M CoxRoy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, United States of America.
Diana L KolbeMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.
Amanda M OdellMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.ORCID https://orcid.org/0000-0003-0212-4683
Chloe E OvelDepartment of Biochemistry and Molecular Biology, University of Iowa, Iowa City, Iowa, United States of America.
Katherine I McCormickMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.
Brian HongMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.
Hela AzaiezMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.
Thomas L CasavantDepartment of Electrical and Computer Engineering, University of Iowa, Iowa City, Iowa, United States of America.
Richard J H SmithMolecular Otolaryngology and Renal Research Laboratories, University of Iowa, Iowa City, Iowa, United States of America.ORCID https://orcid.org/0000-0003-1201-6731
Terry A BraunRoy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, United States of America.
Michael J SchniedersRoy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, United States of America.ORCID https://orcid.org/0000-0003-1260-4592

Funding

NONSYNDROMIC HEARING LOSS--A COLLABORATIVE STUDYR01DC002842 · NIDCD · UNIVERSITY OF IOWA · PI SMITH, RICHARD J.H. · 1996 to 2024
$12.7M
Optimizing Genetic Testing for Deafness for Clinical DiagnosticsR01DC012049 · NIDCD · UNIVERSITY OF IOWA · PI TERRY A BRAUN, Thomas L. Casavant · 2011 to 2026
$8.7M
PREDOCTORAL TRAINING PROGRAM IN BIOTECHNOLOGYT32GM008365 · NIGMS · UNIVERSITY OF IOWA · PI KERNS, ROBERT JOHN · 1990 to 2021
$3.8M
Autosomal Dominant Non-Syndromic Hearing Loss - Its Genetic Diagnosis and TreatmentR01DC017955 · NIDCD · UNIVERSITY OF IOWA · PI SMITH, RICHARD J.H. · 2019 to 2023
$2.6M
NIDCD NIH HHS R01 DC002842NIDCD NIH HHS R01 DC012049NIDCD NIH HHS R01 DC017955NIGMS NIH HHS T32 GM008365
6 · The paper itself

Abstract

Hearing loss is the most common sensory deficit impacting ~5% of the world's population. The Deafness Variation Database (DVD) is a public resource of deafness variants, containing 381,924 missense variants across 224 genes, with 303,577 classified as a variant of uncertain significance (VUS). To address the challenge of evaluating each deafness associated VUS, we evaluate a family of probabilistic frameworks to quantify the strength of computational evidence based on ACMG/AMP recommendations. First, CADD and REVEL are compared using Bayesian models parameterized using either a ClinVar 2019 dataset or labeled DVD variants. The REVEL model built using the DVD dataset demonstrates the best accuracy, sensitivity, and specificity. Incorporation of (in)tolerance to missense variation based on sorting each gene into three bins (tolerant, average, intolerant) shows that intolerant DVD genes are consistent with a higher prior probability of being pathogenic (25.7%) than average (10.7%) or tolerant (8.7%) genes. Finally, the impact of protein folding stability was incorporated into the Bayesian model and surpassed the simpler versions while also offering a biophysical rationale for the disease mechanism. The 28,866 VUSs that reach a posterior probability of pathogenicity above 98% based on the protein-folding informed Bayesian model were prioritized as likely to be pathogenic. Overall, 54,752 missense variants (14.3% of 381,924) are predicted to cause modest protein folding destabilization of greater than 1.0 kcal/mol, while 18,706 of these are prioritized VUSs (34% of 54,752). 22,237 missense variants (6.2% of 381,924) are predicted to cause more severe protein folding destabilization of at least 2 kcal/mol with 12,424 being prioritized VUSs (55.8% of 22,237). From these VUSs, we identify twelve probands where the patient's genetic diagnosis is upgraded to likely pathogenic/pathogenic. We highlight two variants that cause clear structural disruption, demonstrating the impact of biophysical characterization on variant evaluation.

Indexed as

DeafnessProtein FoldingProteostasis DeficienciesBayes TheoremDatabases, GeneticHumansMutation, Missense

Identifiers

PMID42814786
PMCPMC13641712

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.